Patheon is a global provider of development and commercial manufacturing services for solid and sterile prescription drugs, offering a wide variety of services and products. SEE AND Read More »

Want to learn more?

Patheon Overview Brochure

Emerging Pharma

 

You make discoveries. We’ll make them into products.

Patheon works with hundreds of emerging pharmaceutical companies to achieve clinical proof of concept. These companies often have limited funding, significant time pressures, and little experience or resources beyond the earliest stages of development. Patheon gives them instant access to all the technologies and expertise required to quickly and cost-efficiently transform their discoveries into viable products.

In order to meet the distinct needs of our emerging pharma clients, Patheon has built facilities dedicated to early development. We have also created unique programs such as SoluPath™Quick-to-Clinic™, and Patheon Certified Consultants™ that have proven processes in place to overcome the challenges common at this stage. What’s more, they benefit from our decades of experience across the entire drug development process. The formulations we develop accomplish their immediate goals while establishing a scientifically sound foundation for a smooth transition to late development, scale-up and commercial supply.

With expertise amassed from thousands of projects, Patheon works with startups to tailor an efficient preclinical and clinical development program of carefully selected services that balances risk and return, and charts the path to success.

Ask The Experts

Anil Kane, Ph.D., MBA

Anil Kane, Ph.D., MBA
Dr. Kane has more than 25 years of experience in the science and business of taking molecules throug
Read More »

Kaspar van den Dries, Ph.D.

Kaspar van den Dries, Ph.D.
Based at our Tilburg facility in the Netherlands, Dr. van den Dries leads Patheon’s European researc
Read More »

Jason Vaughn, Ph.D.

Jason Vaughn, Ph.D.
Dr. Vaughn has expertise in early and preclinical development of liquid, semi-solid and solid dosage
Read More »

Roman Hlodan, Ph.D.

Roman Hlodan, Ph.D.
Dr. Hlodan is an expert in the development of biopharmaceuticals, including analytical method devel
Read More »

Stephen Closs

Stephen Closs
Mr. Closs possess more than 23 years of experience in formulation development, tech transfer, scale-
Read More »

William E. Weiser, Ph.D.

William E. Weiser, Ph.D.
Dr. Weiser is an expert in analytical method development and validation for APIs and drug products.
Read More »

View All »

Knowledge Library


Please fill the below form to access requested content

First Name

Last Name

Company

Title

Email

Phone

Address Line 1

Address Line 2

City

Zip/ Postal Code

Country

Submit